Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (231-240 of 477) with videos related to

Pageof 48
Sort By:
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
The Journal of Rheumatology|October 7, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritisDaniel E Furst, Michael Weisman, Harold E Paulus, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
Frontiers in Immunology|September 25, 2018
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?Cosimo Bruni, Tracy Frech, Mirko Manetti, et al.
Cureus|October 2, 2024
Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological ChangesSomit Kumar, Karthikeyan Ramaraju, Mitravinda S Kakarla, et al.
The American Journal of Medicine|May 3, 2011
Adverse events during the Scleroderma Lung StudyDaniel E Furst, Chi-Hong Tseng, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 11, 2006
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patientsJason C Cole, Dinesh Khanna, Philip J Clements, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinicDinesh Khanna, Paul Maranian, Nan Rothrock, et al.
Clinical and Experimental Rheumatology|March 2, 2023
Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy predictionWeijin Zhang, Guohai Huang, Kedi Zheng, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritisDaniel E Furst, Manorama M Venkatraman, B G Krishna Swamy, et al.
Pageof 48

Showing results (231-240 of 477) with videos related to

Sort By:
Pageof 48
Arthritis and Rheumatism|October 2, 2007
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentDinesh Khanna, Ron D Hays, Grace S Park, et al.
The Journal of Rheumatology|October 7, 2003
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritisDaniel E Furst, Michael Weisman, Harold E Paulus, et al.
Arthritis Care & Research|August 27, 2010
Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung studyKaren Au, Maureen D Mayes, Paul Maranian, et al.
Frontiers in Immunology|September 25, 2018
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?Cosimo Bruni, Tracy Frech, Mirko Manetti, et al.
Cureus|October 2, 2024
Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological ChangesSomit Kumar, Karthikeyan Ramaraju, Mitravinda S Kakarla, et al.
The American Journal of Medicine|May 3, 2011
Adverse events during the Scleroderma Lung StudyDaniel E Furst, Chi-Hong Tseng, Philip J Clements, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 11, 2006
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patientsJason C Cole, Dinesh Khanna, Philip J Clements, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinicDinesh Khanna, Paul Maranian, Nan Rothrock, et al.
Clinical and Experimental Rheumatology|March 2, 2023
Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy predictionWeijin Zhang, Guohai Huang, Kedi Zheng, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritisDaniel E Furst, Manorama M Venkatraman, B G Krishna Swamy, et al.
Pageof 48